SOTERA HEALTH COMPANY Increase (Decrease) in Other Noncurrent Assets
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Other Noncurrent Assets of $3.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $1.97M, a 316.91% increase year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $1.71M, a 191.65% increase year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$552.00K, a 131.44% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$720.00K, a 138.83% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for fiscal 2025 was -$212.00K, a 103.10% decline from fiscal 2024.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for fiscal 2024 was $6.84M, a 2774.79% increase from fiscal 2023.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for fiscal 2023 was $238.00K, a 94.81% decline from fiscal 2022.
- SOTERA HEALTH COMPANY increase (decrease) in other noncurrent assets for fiscal 2022 was $4.59M, a 4.87% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.68M 10-Q · filed 2026-08-06 | $3.13M derived: sum of 3 quarters · filed 2026-08-06 | $2.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.71M 10-Q · filed 2026-05-05 | $1.16M derived: sum of 2 quarters · filed 2026-05-05 | $440.00K derived: sum of 3 quarters · filed 2026-05-05 | $913.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.27M derived: sum of 2 quarters · filed 2026-02-24 | -$799.00K derived: sum of 3 quarters · filed 2026-08-06 | -$212.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | -$720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$247.00K derived: sum of 2 quarters · filed 2026-08-06 | $340.00K 10-Q · filed 2025-11-04 | $2.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $473.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.06M 10-Q · filed 2026-08-06 | $2.82M derived: sum of 3 quarters · filed 2026-08-06 | $4.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $587.00K 10-Q · filed 2026-05-05 | $2.34M derived: sum of 2 quarters · filed 2026-05-05 | $4.20M derived: sum of 3 quarters · filed 2026-05-05 | $5.21M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.61M derived: sum of 2 quarters · filed 2026-02-24 | $4.62M derived: sum of 3 quarters · filed 2026-02-24 | $6.84M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.86M derived: sum of 2 quarters · filed 2025-11-04 | $5.09M 10-Q · filed 2025-11-04 | $1.15M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.23M 10-Q · filed 2025-08-08 | -$701.00K derived: sum of 3 quarters · filed 2026-02-24 | $3.83M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $2.22M 10-Q · filed 2025-05-01 | -$1.71M derived: sum of 2 quarters · filed 2026-02-24 | $2.82M derived: sum of 3 quarters · filed 2026-02-24 | $2.57M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $596.00K derived: sum of 2 quarters · filed 2026-02-24 | $342.00K derived: sum of 3 quarters · filed 2026-02-24 | $238.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $4.28M derived: sum of 2 quarters · filed 2024-11-05 | $4.17M 10-Q · filed 2024-11-05 | $4.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$358.00K 10-Q · filed 2024-08-05 | -$28.00K derived: sum of 3 quarters · filed 2025-02-27 | -$195.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$104.00K 10-Q · filed 2024-05-02 | $226.00K derived: sum of 2 quarters · filed 2025-02-27 | $59.00K derived: sum of 3 quarters · filed 2025-02-27 | $4.14M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $163.00K derived: sum of 2 quarters · filed 2025-02-27 | $4.25M derived: sum of 3 quarters · filed 2025-02-27 | $4.59M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $3.92M derived: sum of 2 quarters · filed 2023-11-01 | $4.26M 10-Q · filed 2023-11-01 | $8.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.43M 10-Q · filed 2023-08-03 | $8.45M derived: sum of 3 quarters · filed 2024-02-27 | $8.79M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $341.00K 10-Q · filed 2023-05-03 | $4.37M derived: sum of 2 quarters · filed 2024-02-27 | $4.70M derived: sum of 3 quarters · filed 2024-02-27 | $4.43M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.36M derived: sum of 2 quarters · filed 2024-02-27 | $4.09M derived: sum of 3 quarters · filed 2024-02-27 | $4.38M 10-K · filed 2024-02-27 |
| 2021-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $67.00K derived: sum of 2 quarters · filed 2022-11-02 | $349.00K 10-Q · filed 2022-11-02 | $18.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $15.00K 10-Q · filed 2022-08-04 | -$316.00K derived: sum of 3 quarters · filed 2023-02-28 | -$220.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $282.00K 10-Q · filed 2022-05-05 | -$49.00K derived: sum of 2 quarters · filed 2023-02-28 | $47.00K derived: sum of 3 quarters · filed 2023-02-28 | -$651.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$235.00K derived: sum of 2 quarters · filed 2023-02-28 | -$933.00K derived: sum of 3 quarters · filed 2023-02-28 | -$1.82M 10-K · filed 2023-02-28 |
| 2020-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$602.00K derived: sum of 2 quarters · filed 2021-11-10 | -$1.49M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.59M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$889.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $735.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |